HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indium-111-antimyosin uptake in acute and remote myocardial infarction: comparison with pathohistologic findings.

Abstract
Indium-111-Fab antimyosin antibody accumulation was studied in an 81-yr-old patient who was treated twice for unstable angina on ECG, signs of apicoseptal infarction, anterolateral and inferior ischemia without clinical evidence of an acute coronary event. During the last hospitalization, 9 and 3 mo after the previous ones, additional ischemia in the inferoposterior wall was demonstrated. Antimyosin was administered to detect acute infarction but pump failure developed and the patient died. Autopsy confirmed all stages of infarction on the anterior and lateral walls, predominant fibrosis in the apicoseptal region and predominant acute necrosis in the inferior wall. Macroscopic and scintigraphic examinations of transverse slices gave concordant results. A mixture of infarctions and normal tissue was confirmed by histologic findings. Antimyosin antibody accumulation was seen in areas of acute necrosis or bordering areas of reduced uptake in myocardium with remote damage, probably caused by prolonged episodes of unstable angina without evident acute coronary event.
AuthorsN V Budihna, M Micinski, D Latifić-Jasnic, A Cerar
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 33 Issue 4 Pg. 587-9 (Apr 1992) ISSN: 0161-5505 [Print] United States
PMID1552346 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Organometallic Compounds
  • imciromab pentetate
Topics
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Female
  • Humans
  • Myocardial Infarction (diagnostic imaging, pathology)
  • Organometallic Compounds
  • Radioimmunodetection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: